Ratings by Jones Trading (Soumit Roy)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/6/2026 | Day One Biopharmaceuticals | DAWN | Downgrade | Hold (Buy) |
12.78 (21.20) |
65.88% | Details | |
| 1/15/2026 | Nuvation Bio Inc | NUVB | Maintain | Buy (N/A) |
|
Details | ||
| 12/22/2025 | Whitehawk Therapeutics | WHWK | New Coverage | Buy (N/A) |
2.56 (3.75) |
46.48% | Details | |
| 12/22/2025 | Context Therapeutics | CNTX | New Coverage | Buy (Buy) |
1.27 (3.12) |
145.67% | Details | |
| 11/26/2025 | Cullinan Oncology Inc. | CGEM | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2025 | Day One Biopharmaceuticals | DAWN | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2025 | Janux Therapeutics | JANX | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2025 | OnKure Therapeutics Inc. | OKUR | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2025 | Evaxion Biotech | EVAX | New Coverage | Buy (N/A) |
6.48 (3.22) |
-50.31% | Details | |
| 10/23/2025 | Anavex Life Sciences | AVXL | Downgrade | Hold (Buy) |
9.35 (4.65) |
-50.27% | Details | |
| 10/10/2025 | Monopar Therapeutics | MNPR | New Coverage | Buy (N/A) |
100.96 (57.61) |
-42.94% | Details | |
| 9/17/2025 | Elicio Therapeutics | ELTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/15/2025 | aTyr Pharma | ATYR | Downgrade | Hold (Buy) |
6.03 (0.82) |
-86.4% | Details | |
| 9/9/2025 | Bicara Therapeutics Inc | BCAX | New Coverage | Buy (N/A) |
12.29 (18.47) |
50.28% | Details | |
| 9/8/2025 | CG Oncology | CGON | New Coverage | Buy (N/A) |
33.07 (61.88) |
87.12% | Details | |
| 7/28/2025 | CervoMed | CRVO | Maintain | Buy (N/A) |
|
Details | ||
| 5/22/2025 | Protera Therapeutics | TARA | New Coverage | Buy (N/A) |
3.25 (5.90) |
81.54% | Details | |
| 5/20/2025 | ArriVent BioPharma | AVBP | New Coverage | Buy (N/A) |
19.35 (23.43) |
21.09% | Details | |
| 5/16/2025 | Enliven Therapeutics | ELVN | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2025 | Acrivon Therapeutics Inc | ACRV | Downgrade | Hold (Buy) |
1.10 (1.55) |
40.91% | Details | |
| 5/16/2025 | Oncolytics Biotech | ONCY | Downgrade | Hold (Buy) |
0.50 (1.06) |
112% | Details | |
| 4/11/2025 | Adaptimmune Therapeutics plc | ADAP | Downgrade | Hold (Buy) |
0.22 (0.05) |
-77.27% | Details | |
| 3/25/2025 | Mural Oncology | MURA | Downgrade | Hold (Buy) |
3.83 (2.04) |
-46.74% | Details | |
| 3/13/2025 | CervoMed | CRVO | Upgrade | Buy (Hold) |
6.17 (4.11) |
-33.39% | Details | |
| 3/12/2025 | Nuvation Bio Inc | NUVB | New Coverage | Buy (N/A) |
1.88 (4.59) |
144.15% | Details | |
| 3/10/2025 | Beam Therapeutics Inc | BEAM | Upgrade | Buy (Hold) |
28.48 (26.54) |
-6.81% | Details | |
| 3/6/2025 | Elicio Therapeutics | ELTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2025 | Chimerix | CMRX | Downgrade | Hold (Buy) |
4.96 (8.54) |
72.18% | Details | |
| 2/11/2025 | IN8bio Inc. | INAB | Upgrade | Buy (Hold) |
0.27 (1.72) |
537.04% | Details | |
| 2/10/2025 | ORIC Pharamceuticals | ORIC | Maintain | Buy (N/A) |
|
Details | ||
| 1/27/2025 | Mural Oncology | MURA | New Coverage | Buy (N/A) |
3.95 (3.83) |
-3.04% | Details | |
| 12/13/2024 | Editas Medicine | EDIT | Downgrade | Hold (Buy) |
1.89 (2.00) |
5.82% | Details | |
| 12/10/2024 | CervoMed | CRVO | Downgrade | Hold (Buy) |
10.25 (4.11) |
-59.9% | Details | |
| 12/3/2024 | Janux Therapeutics | JANX | Maintain | Buy (N/A) |
|
Details | ||
| 11/25/2024 | Cassava Sciences | SAVA | Maintain | Hold (Hold) |
|
Details | ||
| 11/1/2024 | ESSA Pharma | EPIX | Downgrade | Hold (Buy) |
5.20 (0.20) |
-96.15% | Details | |
| 10/31/2024 | ORIC Pharamceuticals | ORIC | New Coverage | Buy (N/A) |
9.00 (13.71) |
52.33% | Details | |
| 10/31/2024 | Enliven Therapeutics | ELVN | New Coverage | Buy (N/A) |
28.52 (29.44) |
3.23% | Details | |
| 10/31/2024 | Elicio Therapeutics | ELTX | New Coverage | Buy (N/A) |
4.31 (11.63) |
169.84% | Details | |
| 10/9/2024 | aTyr Pharma | ATYR | Maintain | Buy (N/A) |
|
Details | ||
| 9/30/2024 | Prime Medicine | PRME | Maintain | Buy (N/A) |
|
Details | ||
| 9/27/2024 | Curis | CRIS | Maintain | Buy (N/A) |
|
Details | ||
| 9/17/2024 | Editas Medicine | EDIT | New Coverage | Buy (N/A) |
3.83 (2.00) |
-47.78% | Details | |
| 9/17/2024 | Beam Therapeutics Inc | BEAM | New Coverage | Hold (N/A) |
25.62 (28.48) |
11.16% | Details | |
| 9/10/2024 | Adicet Bio Inc. | ACET | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2024 | IN8bio Inc. | INAB | Downgrade | Hold (Buy) |
0.70 (0.27) |
-61.43% | Details | |
| 8/6/2024 | Anavex Life Sciences | AVXL | Maintain | Buy (N/A) |
|
Details | ||
| 7/19/2024 | Adaptimmune Therapeutics plc | ADAP | Maintain | Buy (N/A) |
|
Details | ||
| 7/1/2024 | Cassava Sciences | SAVA | Downgrade | Hold (Buy) |
12.35 (2.03) |
-83.56% | Details | |
| 6/13/2024 | IN8bio Inc. | INAB | Maintain | Buy (N/A) |
|
Details | ||
| 5/30/2024 | Adaptimmune Therapeutics plc | ADAP | Maintain | Buy (N/A) |
|
Details | ||
| 5/29/2024 | CervoMed | CRVO | New Coverage | Buy (N/A) |
18.69 (4.11) |
-78.01% | Details | |
| 5/15/2024 | Bolt Biotherapeutics, Inc. | BOLT | Downgrade | Hold (Buy) |
1.32 (4.30) |
225.76% | Details | |
| 5/9/2024 | Anavex Life Sciences | AVXL | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2024 | Deciphera | DCPH | Downgrade | Hold (Buy) |
14.65 (25.59) |
74.68% | Details | |
| 4/25/2024 | Acrivon Therapeutics Inc | ACRV | Maintain | Buy (N/A) |
|
Details | ||
| 4/24/2024 | Day One Biopharmaceuticals | DAWN | Maintain | Buy (N/A) |
|
Details | ||
| 4/16/2024 | Cullinan Oncology Inc. | CGEM | Maintain | Buy (N/A) |
|
Details | ||
| 4/16/2024 | Janux Therapeutics | JANX | New Coverage | Buy (N/A) |
52.65 (13.84) |
-73.71% | Details | |
| 4/11/2024 | Monopar Therapeutics | MNPR | Upgrade | Buy (Hold) |
0.64 (0.64) |
0% | Details | |
| 3/27/2024 | Aptose Biosciences | APTO | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2024 | Precision BioSciences Inc. | DTIL | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2024 | Day One Biopharmaceuticals | DAWN | Maintain | Buy (N/A) |
|
Details | ||
| 3/13/2024 | IN8bio Inc. | INAB | New Coverage | Buy (N/A) |
1.27 (1.72) |
35.43% | Details | |
| 3/7/2024 | Adaptimmune Therapeutics plc | ADAP | Upgrade | Buy (Hold) |
1.71 (0.05) |
-97.08% | Details | |
| 2/13/2024 | Adicet Bio Inc. | ACET | Upgrade | Buy (Hold) |
3.12 (7.29) |
133.65% | Details | |
| 10/30/2023 | Deciphera | DCPH | Upgrade | Buy (Hold) |
10.15 (25.59) |
152.12% | Details | |
| 10/9/2023 | Mirati Therapeutics | MRTX | Downgrade | Hold (Buy) |
62.38 (58.70) |
-5.9% | Details | |
| 10/5/2023 | Cullinan Oncology Inc. | CGEM | New Coverage | Buy (N/A) |
8.12 (15.74) |
93.84% | Details | |
| 8/18/2023 | Tracon Pharmaceuticals | TCON | Downgrade | Hold (Buy) |
0.20 (1.43) |
615% | Details | |
| 8/18/2023 | Acrivon Therapeutics Inc | ACRV | New Coverage | Buy (N/A) |
11.26 (1.55) |
-86.23% | Details | |
| 8/10/2023 | Monopar Therapeutics | MNPR | Downgrade | Hold (Buy) |
0.73 (57.61) |
7791.78% | Details | |
| 5/24/2023 | Oncolytics Biotech | ONCY | New Coverage | Buy (N/A) |
1.91 (1.06) |
-44.5% | Details | |
| 5/22/2023 | Rain Therapeutics | RAIN | Downgrade | Hold (Buy) |
9.93 (2.80) |
-71.8% | Details | |
| 4/12/2023 | Aeglea Biotherapeutics | AGLE | Downgrade | Hold (Buy) |
0.26 (12.01) |
4519.23% | Details | |
| 3/6/2023 | Adaptimmune Therapeutics plc | ADAP | Downgrade | Hold (Buy) |
1.76 (0.05) |
-97.16% | Details | |
| 1/6/2023 | Deciphera | DCPH | Upgrade | Hold (Sell) |
19.76 (25.59) |
29.5% | Details | |
| 12/13/2022 | Mirati Therapeutics | MRTX | Maintain | Buy (N/A) |
|
Details | ||
| 12/2/2022 | Anavex Life Sciences | AVXL | Maintain | Buy (N/A) |
|
Details | ||
| 11/16/2022 | Inhibikase Therapeutics Inc | IKT | Downgrade | Hold (Buy) |
0.54 (1.88) |
248.15% | Details | |
| 11/8/2022 | HCW Biologics Inc. | HCWB | New Coverage | Buy (N/A) |
2.25 (0.62) |
-72.44% | Details | |
| 10/31/2022 | AVEO Pharmaceuticals | AVEO | Downgrade | Hold (Buy) |
14.77 (15.00) |
1.56% | Details | |
| 9/6/2022 | Day One Biopharmaceuticals | DAWN | New Coverage | Buy (N/A) |
23.76 (12.78) |
-46.21% | Details | |
| 8/12/2022 | Infinity Pharmaceutical | INFI | Downgrade | Hold (Buy) |
1.08 (0.04) |
-96.3% | Details | |
| 8/1/2022 | Aileron Therapeutics Inc | ALRN | Downgrade | Hold (Buy) |
0.19 (2.11) |
1010.53% | Details | |
| 7/20/2022 | Vascular Biogenics Ltd | VBLT | Downgrade | Hold (Buy) |
2.05 (0.16) |
-92.2% | Details | |
| 6/30/2022 | Aileron Therapeutics Inc | ALRN | Downgrade | Hold (Buy) |
0.41 (2.11) |
414.63% | Details | |
| 6/23/2022 | Rain Therapeutics | RAIN | New Coverage | Buy (N/A) |
2.36 (2.80) |
18.64% | Details | |
| 5/10/2022 | Precision BioSciences Inc. | DTIL | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2022 | Silverback Therapeutics | SBTX | Downgrade | Hold (Buy) |
3.51 (5.87) |
67.24% | Details | |
| 3/14/2022 | AVEO Pharmaceuticals | AVEO | New Coverage | Buy (N/A) |
3.78 (15.00) |
296.83% | Details | |
| 3/26/2021 | Celyad SA | CYAD | Downgrade | Hold (Buy) |
7.61 (0.47) |
-93.82% | Details | |
| 3/17/2021 | Cassava Sciences | SAVA | New Coverage | Buy (N/A) |
52.16 (12.35) |
-76.32% | Details | |
| 2/22/2021 | Aptose Biosciences | APTO | New Coverage | Buy (N/A) |
4.31 (1.71) |
-60.32% | Details | |
| 7/2/2020 | T2 Biosystems, Inc | TTOO | Maintain | Buy (N/A) |
|
Details | ||
| 6/19/2020 | Trillium Therapeutics | TRIL | New Coverage | Buy (N/A) |
8.23 (19.86) |
141.31% | Details | |
| 5/29/2020 | Adaptimmune Therapeutics plc | ADAP | Upgrade | Buy (Hold) |
4.86 (0.05) |
-98.97% | Details | |
| 4/29/2020 | Deciphera | DCPH | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2020 | Forty Seven Inc. | FTSV | Downgrade | Hold (Buy) |
93.91 (95.51) |
1.7% | Details | |
| 8/1/2019 | T2 Biosystems, Inc | TTOO | Downgrade | Hold (Buy) |
1.44 (0.13) |
-90.97% | Details |
